Skip to main navigation

Investor Relations

  • Overview
  • Business Principles
  • Events
  • Corporate Governance
    • Management
    • Board of Directors
    • Committees
    • Contact the Board
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
  • Stock Information
    • Historic Stock Lookup
    • Analyst Coverage
  • Investor FAQs
  • Press Releases
  • Investor Contacts

Shareholder Tools

  • Email Alerts
  • Download Library
  • Printed Materials
  • RSS News Feeds
Print   Share
Share this on: Close window
delicious Delicious
Digg Digg
Facebook Facebook
LinkedIn LinkedIn
Twitter Twitter

Ironwood Pharmaceuticals 2Q 2018 Investor Update Conference Call

Aug 6, 2018 at 8:30 AM EDT

Listen to webcast

Supporting Materials

View Presentation 334.7 KB

Ironwood Pharmaceuticals
301 Binney Street
Cambridge, MA 02142

tel 617.621.7722
fax 617.494.0480

ABOUT US

Overview

Core Values

Management Team

Founders

Board of Directors

Pharmaceutical
Advisory Committee

Contact Us

Transparency

Patient Assistance

Our MEDICINES

Overview

Discovery of Linaclotide

Global Strategy

R&D

Overview

Approach

COLLABORATE

Overview

Accessing Additional Products

Globalization

Investors

Investor

  • Overview
  • Business Principles
  • Events
  • Corporate Governance
    • Management
    • Board of Directors
    • Committees
    • Contact the Board
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
  • Stock Information
    • Historic Stock Lookup
    • Analyst Coverage
  • Investor FAQs
  • Press Releases
  • Investor Contacts

NEWS

IR Menu PR

  • News
  • Press Releases
  • Social Media
  • Multimedia
  • Resources

Join US

Overview

Career Openings

Sales Openings

Our Community

Our Expertise

Copyright © 2018, Ironwood Pharmaceuticals, Inc. All Rights Reserved    |    Privacy Policy    |    Terms of Service   |    Site Design

LINZESS® is a registered trademark of Ironwood Pharmaceuticals, Inc., ZURAMPIC®, DUZALLO® are registered trademarks of AstraZeneca AB Corporation or its affiliates and are used herein under license.

You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.